These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17530212)

  • 41. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.
    Ng WH; Lim T
    J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adult brain tumors: clinical applications of magnetic resonance spectroscopy.
    Brandão LA; Castillo M
    Neuroimaging Clin N Am; 2013 Aug; 23(3):527-55. PubMed ID: 23928203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance.
    Fulham MJ; Bizzi A; Dietz MJ; Shih HH; Raman R; Sobering GS; Frank JA; Dwyer AJ; Alger JR; Di Chiro G
    Radiology; 1992 Dec; 185(3):675-86. PubMed ID: 1438744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
    Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
    Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing tumors of bone and soft tissue].
    Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):504-10. PubMed ID: 22338133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.
    Law M; Hamburger M; Johnson G; Inglese M; Londono A; Golfinos J; Zagzag D; Knopp EA
    Technol Cancer Res Treat; 2004 Dec; 3(6):557-65. PubMed ID: 15560713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MR Spectroscopy for Differentiating Benign From Malignant Solid Adnexal Tumors.
    Ma FH; Qiang JW; Cai SQ; Zhao SH; Zhang GF; Rao YM
    AJR Am J Roentgenol; 2015 Jun; 204(6):W724-30. PubMed ID: 26001263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
    Warrington CD; Feeney DA; Ober CP; Jessen CR; Steward SM; Armién AG; Fletcher TF
    Am J Vet Res; 2013 Oct; 74(10):1291-303. PubMed ID: 24066913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors.
    Astrakas LG; Zurakowski D; Tzika AA; Zarifi MK; Anthony DC; De Girolami U; Tarbell NJ; Black PM
    Clin Cancer Res; 2004 Dec; 10(24):8220-8. PubMed ID: 15623597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy.
    Richards TL
    AJR Am J Roentgenol; 1991 Nov; 157(5):1073-8. PubMed ID: 1927795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors.
    Tien RD; Lai PH; Smith JS; Lazeyras F
    AJR Am J Roentgenol; 1996 Jul; 167(1):201-9. PubMed ID: 8659372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
    Ziegler A; von Kienlin M; Décorps M; Rémy C
    Cancer Res; 2001 Jul; 61(14):5595-600. PubMed ID: 11454713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors.
    Spampinato MV; Smith JK; Kwock L; Ewend M; Grimme JD; Camacho DL; Castillo M
    AJR Am J Roentgenol; 2007 Jan; 188(1):204-12. PubMed ID: 17179366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo 1H NMR spectroscopy of an intracerebral glioma in the rat.
    Remy C; Von Kienlin M; Lotito S; Francois A; Benabid AL; Decorps M
    Magn Reson Med; 1989 Mar; 9(3):395-401. PubMed ID: 2710005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perfusion MR imaging and MR spectroscopy of gemistocytic astrocytoma.
    Godefroy A; Derrey S; Laquerrière A; Perot G; Proust F; Gerardin E
    J Neuroradiol; 2012 Jul; 39(3):190-4. PubMed ID: 22115534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolite Levels in Paediatric Brain Tumours Correlate with Histological Features.
    Orphanidou-Vlachou E; Kohe SE; Brundler MA; MacPherson L; Sun Y; Davies N; Wilson M; Pan X; Arvanitis TN; Grundy RG; Peet AC
    Pathobiology; 2018; 85(3):157-168. PubMed ID: 29428932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiparametric MR Imaging in the Assessment of Brain Tumors.
    Kimura M; da Cruz LCH
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):87-122. PubMed ID: 26613877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative sodium MR imaging and sodium bioscales for the management of brain tumors.
    Thulborn KR; Lu A; Atkinson IC; Damen F; Villano JL
    Neuroimaging Clin N Am; 2009 Nov; 19(4):615-24. PubMed ID: 19959008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications.
    Panigrahy A; Nelson MD; Blüml S
    Pediatr Radiol; 2010 Jan; 40(1):3-30. PubMed ID: 19937238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [MR spectroscopy of brain tumors].
    Galanaud D; Nicoli F; Figarella-Branger D; Roche P; Confort-Gouny S; Le Fur Y; Cozzone PJ
    J Radiol; 2006 Jun; 87(6 Pt 2):822-32. PubMed ID: 16778750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.